Drooid Logo
Back to today’s briefing

Story perspectives

Doctor Warns of 'Ozempic Vagina' Risks for Women

9/13/2025

32 2

1 of 1

Story summary
  • Dr. Natasha Bhuyan addresses "Ozempic vagina," which describes vulvar changes following weight loss from GLP-1 medications.
  • Rapid fat loss may cause vaginal dryness and pelvic floor weakness due to estrogen deficiency.
  • GLP-1 drugs, including Ozempic, are not advised during pregnancy or breastfeeding.
  • Concerns exist regarding GLP-1s potentially impacting oral contraceptive effectiveness.
  • Women should seek guidance from healthcare providers for tailored treatment and symptom management.